News
Nutcracker Therapeutics Strengthens Leadership Team with Appointment of Madhavan Balachandran as Chief Operating Officer
Emeryville, Calif. – September 23, 2020 – Nutcracker Therapeutics, Inc., a company developing and producing mRNA therapeutics on its proprietary, microfluidic, biochip-based platform, today announced the appointment of Madhavan (“Madhu”) Balachandran, former executive vice president Read more…